Literature DB >> 20223681

Deciphering modifications in swine cardiac troponin I by top-down high-resolution tandem mass spectrometry.

Jiang Zhang1, Xintong Dong, Timothy A Hacker, Ying Ge.   

Abstract

Cardiac troponin I (cTnI) is an important regulatory protein in cardiac muscle, and its modification represents a key mechanism in the regulation of cardiac muscle contraction and relaxation. cTnI is often referred to as the "gold-standard" serum biomarker for diagnosing patients with acute cardiac injury since it is unique to the heart and released into the circulation following necrotic death of cardiac tissue. The swine (Sus scrofa) heart model is extremely valuable for cardiovascular research since the heart anatomy and coronary artery distribution of swine are almost identical to those of humans. Herein, we report a comprehensive characterization of the modifications in swine cTnI using top-down high-resolution tandem mass spectrometry in conjugation with immunoaffinity chromatography purification. High-resolution high accuracy mass spectrometry revealed that swine cTnI affinity purified from domestic pig hearts was N-terminally acetylated and phosphorylated. Electron capture disassociation is uniquely suited for localization of labile phosphorylations, which unambiguously identified Ser22/Ser23 as the only basally phosphorylated sites that are well-known to be regulated by protein kinase A and protein kinase C. Moreover, a combination of tandem mass spectrometry with sequence homology alignment effectively localized a single amino acid polymorphism, V116A, representing a novel genetic variant of swine cTnI. Overall, our studies demonstrated the unique power of top-down high-resolution tandem mass spectrometry in the characterization of protein modifications, including labile phosphorylation and unexpected sequence variants. Copyright 2010 American Society for Mass Spectrometry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223681      PMCID: PMC3056346          DOI: 10.1016/j.jasms.2010.02.005

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  50 in total

Review 1.  Top-down mass spectrometry of integral membrane proteins.

Authors:  Julian Whitelegge; Frederic Halgand; Puneet Souda; Vlad Zabrouskov
Journal:  Expert Rev Proteomics       Date:  2006-12       Impact factor: 3.940

2.  Extending top-down mass spectrometry to proteins with masses greater than 200 kilodaltons.

Authors:  Xuemei Han; Mi Jin; Kathrin Breuker; Fred W McLafferty
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

3.  Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart.

Authors:  R J Solaro; A J Moir; S V Perry
Journal:  Nature       Date:  1976-08-12       Impact factor: 49.962

Review 4.  Thromboembolic phenomena and the use of the pig as an appropriate animal model for research on cardiovascular devices.

Authors:  D R Gross
Journal:  Int J Artif Organs       Date:  1997-04       Impact factor: 1.595

5.  Transgenic mouse model of stunned myocardium.

Authors:  A M Murphy; H Kögler; D Georgakopoulos; J L McDonough; D A Kass; J E Van Eyk; E Marbán
Journal:  Science       Date:  2000-01-21       Impact factor: 47.728

Review 6.  Regulation of cardiac contractile function by troponin I phosphorylation.

Authors:  Joanne Layland; R John Solaro; Ajay M Shah
Journal:  Cardiovasc Res       Date:  2005-04-01       Impact factor: 10.787

Review 7.  Xenotransplantation of solid organs in the pig-to-primate model.

Authors:  Burcin Ekser; Paolo Rigotti; Bruno Gridelli; David K C Cooper
Journal:  Transpl Immunol       Date:  2008-10-26       Impact factor: 1.708

Review 8.  Animal models of human cardiovascular disease, heart failure and hypertrophy.

Authors:  G Hasenfuss
Journal:  Cardiovasc Res       Date:  1998-07       Impact factor: 10.787

9.  Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins.

Authors:  J van der Velden; Z Papp; R Zaremba; N M Boontje; J W de Jong; V J Owen; P B J Burton; P Goldmann; K Jaquet; G J M Stienen
Journal:  Cardiovasc Res       Date:  2003-01       Impact factor: 10.787

Review 10.  Advances in swine biomedical model genomics.

Authors:  Joan K Lunney
Journal:  Int J Biol Sci       Date:  2007-02-10       Impact factor: 6.580

View more
  35 in total

1.  Phosphorylation, but not alternative splicing or proteolytic degradation, is conserved in human and mouse cardiac troponin T.

Authors:  Jiang Zhang; Han Zhang; Serife Ayaz-Guner; Yi-Chen Chen; Xintong Dong; Qingge Xu; Ying Ge
Journal:  Biochemistry       Date:  2011-06-15       Impact factor: 3.162

2.  AMP-activated protein kinase phosphorylates cardiac troponin I at Ser-150 to increase myofilament calcium sensitivity and blunt PKA-dependent function.

Authors:  Benjamin R Nixon; Ariyoporn Thawornkaiwong; Janel Jin; Elizabeth A Brundage; Sean C Little; Jonathan P Davis; R John Solaro; Brandon J Biesiadecki
Journal:  J Biol Chem       Date:  2012-04-06       Impact factor: 5.157

3.  Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure.

Authors:  Jiang Zhang; Moltu J Guy; Holly S Norman; Yi-Chen Chen; Qingge Xu; Xintong Dong; Huseyin Guner; Sijian Wang; Takushi Kohmoto; Ken H Young; Richard L Moss; Ying Ge
Journal:  J Proteome Res       Date:  2011-07-28       Impact factor: 4.466

Review 4.  Analysis of intact protein isoforms by mass spectrometry.

Authors:  Jeremiah D Tipton; John C Tran; Adam D Catherman; Dorothy R Ahlf; Kenneth R Durbin; Neil L Kelleher
Journal:  J Biol Chem       Date:  2011-06-01       Impact factor: 5.157

Review 5.  Protein phosphorylation and signal transduction in cardiac thin filaments.

Authors:  R John Solaro; Tomoyoshi Kobayashi
Journal:  J Biol Chem       Date:  2011-01-21       Impact factor: 5.157

6.  Simultaneous Quantification of Protein Expression and Modifications by Top-down Targeted Proteomics: A Case of the Sarcomeric Subproteome.

Authors:  Ziqing Lin; Liming Wei; Wenxuan Cai; Yanlong Zhu; Trisha Tucholski; Stanford D Mitchell; Wei Guo; Stephen P Ford; Gary M Diffee; Ying Ge
Journal:  Mol Cell Proteomics       Date:  2018-12-27       Impact factor: 5.911

7.  Comprehensive Characterization of AMP-Activated Protein Kinase Catalytic Domain by Top-Down Mass Spectrometry.

Authors:  Deyang Yu; Ying Peng; Serife Ayaz-Guner; Zachery R Gregorich; Ying Ge
Journal:  J Am Soc Mass Spectrom       Date:  2016-02       Impact factor: 3.109

Review 8.  Top-down mass spectrometry of cardiac myofilament proteins in health and disease.

Authors:  Ying Peng; Serife Ayaz-Guner; Deyang Yu; Ying Ge
Journal:  Proteomics Clin Appl       Date:  2014-08       Impact factor: 3.494

9.  Top-down targeted proteomics for deep sequencing of tropomyosin isoforms.

Authors:  Ying Peng; Xin Chen; Han Zhang; Qingge Xu; Timothy A Hacker; Ying Ge
Journal:  J Proteome Res       Date:  2012-12-20       Impact factor: 4.466

Review 10.  Top-down Proteomics: Technology Advancements and Applications to Heart Diseases.

Authors:  Wenxuan Cai; Trisha M Tucholski; Zachery R Gregorich; Ying Ge
Journal:  Expert Rev Proteomics       Date:  2016-07-26       Impact factor: 3.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.